Food Science and Technology Department, University of Nebraska, Lincoln, Nebraska, USA.
Adv Immunol. 2010;107:71-107. doi: 10.1016/B978-0-12-381300-8.00003-4.
The adaptive immune response to normal gut bacteria is part of a homeostatic process that is neither ignorance nor tolerance. Through both targeted and meta-genome sequencing of the gut microbiota, we now know more about the microbial population that inhabits the gut environment than any previous generation. Defining the specificity of the adaptive immune response to gut symbionts and the impact of this specificity on the gut barrier function is still limited by lack of comprehensive data. The evolution of the gut microbiota over millenia with its host provides stability to the present-day microbiota in the presence and absence of the adaptive and innate immune system. Intrinsic factors within each member of the microbiota modulate the immunostimulatory capacity of gut bacteria. Three of these factors, ecological fitness, antigenic degeneracy, and pathogenicity, will control the level of immune response to a given organism in the community. Future research that defines the specificity of microbiota-reactive T and B cells will provide insight into both normal homeostasis as well as the pathology of inflammatory and metabolic diseases associated with the gut microbiome.
对正常肠道细菌的适应性免疫反应是体内平衡过程的一部分,既不是无知也不是宽容。通过对肠道微生物组进行靶向和宏基因组测序,我们现在对栖息在肠道环境中的微生物种群的了解比以往任何一代都要多。定义适应性免疫反应对肠道共生体的特异性以及这种特异性对肠道屏障功能的影响仍然受到缺乏全面数据的限制。肠道微生物组与宿主在数千年中的进化为当今微生物组在适应性和先天免疫系统存在和不存在的情况下提供了稳定性。微生物组内的内在因素调节肠道细菌的免疫刺激性。这三个因素,生态适应性、抗原简并性和致病性,将控制对社区中给定生物体的免疫反应水平。未来定义对微生物群反应性 T 和 B 细胞特异性的研究将深入了解与肠道微生物组相关的炎症和代谢疾病的正常体内平衡和病理。